MedTrace Logo

RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALL

NCT05127148 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2024-01-09

No results posted yet for this study

Summary

This is a multicenter, observational real world clinical trial with prospective follow up that will evaluate the treatment outcome of adolescent and young patients with ph-negative acute lymphoblastic leukemia with first-line pediatric-like protocol in Argentina.

Conditions

  • Acute Lymphoblastic Leukemia, Adult

Interventions

OTHER

Evaluation of survival and toxicities in AYA Ph-negative ALL patients treating in first line depending on risk category.

Evaluation of survival (event free survival and overall survival) and toxicities in AYA Ph-negative ALL patients treating in first line with argentinian pediatric-like protocol depending on risk category.

Sponsors & Collaborators

  • Grupo Argentino de Tratamiento de la Leucemia Aguda

    lead OTHER

Principal Investigators

  • Maria Moirano, Dr. · Grupo Argentino de Tratamiento de la Leucemia Aguda

  • Isolda Fernández, Dr. · Grupo Argentino de Tratamiento de la Leucemia Aguda

  • Luciana Ferrari, Dr. · Grupo Argentino de Tratamiento de la Leucemia Aguda

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2026-03-01
Completion
2026-12-01

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05127148 on ClinicalTrials.gov